Clinical trial
Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough
NCT01667042 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- June 30, 2015
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
scleroderma lung